Accurate digital quantification of tau pathology in progressive supranuclear palsy
Abstract The development of novel treatments for Progressive Supranuclear Palsy (PSP) is hindered by a knowledge gap of the impact of neurodegenerative neuropathology on brain structure and function. The current standard practice for measuring postmortem tau histology is semi-quantitative assessment...
Main Authors: | Tanrada Pansuwan, Annelies Quaegebeur, Sanne S. Kaalund, Eric Hidari, Mayen Briggs, James B. Rowe, Timothy Rittman |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-11-01
|
Series: | Acta Neuropathologica Communications |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40478-023-01674-y |
Similar Items
-
Progressive supranuclear palsy: A case report and brief review of the literature
by: Vivek Batheja, MD, et al.
Published: (2024-01-01) -
Pathological Study of a FMR1 Premutation Carrier With Progressive Supranuclear Palsy
by: Martin Paucar, et al.
Published: (2018-08-01) -
Clinical Phenotypes of Progressive Supranuclear Palsy—The Differences in Interleukin Patterns
by: Natalia Madetko-Alster, et al.
Published: (2023-10-01) -
Direct comparison between 18F-Flortaucipir tau PET and quantitative susceptibility mapping in progressive supranuclear palsy
by: Ryota Satoh, et al.
Published: (2024-02-01) -
The Burden of Progressive Supranuclear Palsy on Patients, Caregivers, and Healthcare Systems by PSP Phenotype: A Cross-Sectional Study
by: Demetris Pillas, et al.
Published: (2022-07-01)